T9	Subject 10 29	a 44-year-old woman
T12	Treat-Disorder 103 135	recurrent anaplastic astrocytoma
T13	Age 12 23	44-year-old
T14	Gender 24 29	woman
T15	Effect 35 79	t-MDS (refractory anemia with excess blasts)
T16	Drug 141 153	temozolomide
T11	Treatment 90 159	treatment of recurrent anaplastic astrocytoma with temozolomide (TMZ)
T10	Adverse_event 80 89	following
E1	Adverse_event:T10 
T1	Population 10 11	a
